2 Higgins PJ, Weiner HL. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J Immunol, 1988, 140:440-445
3 Meyer Al, Benson JM, Gienapp LE, et al. Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. J Immunol, 1996, 157:4230-4238
4 Miller A, Lider O, Al-Sabbagh A, et al. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. V. hierarchy of suppressionby myelin basic protein from different species. J neuroimmunol, 1992, 39:243-250
5 Wang ZY, He B, Qiao J, et al. Suppression of experimental autoimmune myasthenia gravis and experimental allergic encephalomyelitis by oral administration of acetycholine receptor and myelin basic protein:double tolerance. J Neuroimmunol, 1995, 63:79-86
6 Whitacre CC, Gienapp IE, Meyer A, et al. Treatment of autoimmune diseases by oral tolerance to autoantigens. Clin Immunol Immunopathol, 1996, 80:31-37
7 Shi FD, Bai XF, Li HL, et al. Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals. clin Exp Immunol, 1998, 111:506-512
8 Weiner HL, Zhang ZJ, Khoury SJ, et al. Antigen-driven peripheral immune tolerance. Ann NY Acad Sci, 1991, 636:227-232
9 Whitacre CC, Gienapp IE, Orosz CG, et al. Oral tolerance in experimental autoimmune encephalomyelitis. J Immunol, 1991, 147:2155-2163
10 Zhang ZJ, Lee CSY, Lider O, et al. Suppression of adjuvant arthritis in lewis rats by oral administration of type II collegen. J Immunol, 1990,145:2489-2493
11 Nusse
nblatt RB, Caspi RR, Mahdi R, et al. Inhibition. of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J Immunol, 1990, 144:1689-1695 12 Zhang ZJ, Davidson L, Eisenbarth G, et al. Suppressi
上一页 [1] [2] [3] [4] [5] 下一页